Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

Cytometry-based analysis of HLA-G functions according to ILT2 expression.

Jacquier A, Dumont C, Carosella ED, Rouas-Freiss N, LeMaoult J.

Hum Immunol. 2020 Feb 18. pii: S0198-8859(19)31390-4. doi: 10.1016/j.humimm.2020.02.001. [Epub ahead of print]

PMID:
32081570
2.

Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-G.

Lombard CA, Sana G, LeMaoult J, Najar M, Ravau J, André F, Bouhtit F, Daouya M, Loustau M, Najimi M, Lagneaux L, Carosella ED, Sokal EM.

J Immunol Res. 2019 Sep 12;2019:8250584. doi: 10.1155/2019/8250584. eCollection 2019.

3.

Influence of hormones on the immunotolerogenic molecule HLA-G: a cross-sectional study in patients with congenital adrenal hyperplasia.

Nguyen LS, Rouas-Freiss N, Funck-Brentano C, Leban M, Carosella ED, Touraine P, Varnous S, Bachelot A, Salem JE.

Eur J Endocrinol. 2019 Nov;181(5):481-488. doi: 10.1530/EJE-19-0379.

PMID:
31505456
4.

CD8+PD-1-ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G.

Dumont C, Jacquier A, Verine J, Noel F, Goujon A, Wu CL, Hung TM, Desgrandchamps F, Culine S, Carosella ED, Rouas-Freiss N, LeMaoult J.

Cancer Immunol Res. 2019 Oct;7(10):1619-1632. doi: 10.1158/2326-6066.CIR-18-0764. Epub 2019 Aug 26.

PMID:
31451484
5.

The Autoimmune Regulator (Aire) transactivates HLA-G gene expression in thymic epithelial cells.

Melo-Lima BL, Poras I, Passos GA, Carosella ED, Donadi EA, Moreau P.

Immunology. 2019 Oct;158(2):121-135. doi: 10.1111/imm.13099. Epub 2019 Aug 19.

PMID:
31322727
6.

Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8+ T cells.

Desgrandchamps F, LeMaoult J, Goujon A, Riviere A, Rivero-Juarez A, Djouadou M, de Gouvello A, Dumont C, Wu CL, Culine S, Verine J, Rouas-Freiss N, Hennequin C, Masson-Lecomte A, Carosella ED.

Oncotarget. 2018 Sep 4;9(69):33160-33169. doi: 10.18632/oncotarget.26036. eCollection 2018 Sep 4.

7.

Extended HLA-G haplotypes in patients with age-related macular degeneration.

Svendsen SG, Nilsson LL, Djurisic S, Funck T, Wu CL, Faber C, Falk MK, Singh A, Sørensen TL, Carosella ED, LeMaoult J, Hviid TVF, Nissen MH.

HLA. 2018 Jul 16. doi: 10.1111/tan.13340. [Epub ahead of print]

PMID:
30009537
8.

The genetic diversity within the 1.4 kb HLA-G 5' upstream regulatory region moderately impacts on cellular microenvironment responses.

Dias FC, Bertol BC, Poras I, Souto BM, Mendes-Junior CT, Castelli EC, Gineau L, Sabbagh A, Rouas-Freiss N, Carosella ED, Donadi EA, Moreau P.

Sci Rep. 2018 Apr 4;8(1):5652. doi: 10.1038/s41598-018-24009-7.

9.

HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma.

De Re V, Caggiari L, Mussolin L, d'Amore ES, Famengo B, De Zorzi M, Martina L, Elia C, Pillon M, Santoro N, Muggeo P, Buffardi S, Bianchi M, Sala A, Farruggia P, Vinti L, Carosella ED, Burnelli R, Mascarin M.

Oncotarget. 2017 Nov 18;8(62):105957-105970. doi: 10.18632/oncotarget.22515. eCollection 2017 Dec 1.

10.

Correction for Bortolotti et al., "Pseudomonas aeruginosa Quorum Sensing Molecule N-(3-Oxododecanoyl)-l-Homoserine-Lactone Induces HLA-G Expression in Human Immune Cells".

Bortolotti D, LeMaoult J, Trapella C, Di Luca D, Carosella ED, Rizzo R.

Infect Immun. 2017 Nov 17;85(12). pii: e00628-17. doi: 10.1128/IAI.00628-17. Print 2017 Dec. No abstract available.

11.

Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4.

Rouas-Freiss N, LeMaoult J, Verine J, Tronik-Le Roux D, Culine S, Hennequin C, Desgrandchamps F, Carosella ED.

Oncoimmunology. 2017 Jul 5;6(9):e1342023. doi: 10.1080/2162402X.2017.1342023. eCollection 2017.

12.

Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients.

Tronik-Le Roux D, Renard J, Vérine J, Renault V, Tubacher E, LeMaoult J, Rouas-Freiss N, Deleuze JF, Desgrandschamps F, Carosella ED.

Mol Oncol. 2017 Nov;11(11):1561-1578. doi: 10.1002/1878-0261.12119. Epub 2017 Sep 13.

13.

Expression and differential regulation of HLA-G isoforms in the retinal pigment epithelial cell line, ARPE-19.

Svendsen SG, Udsen MS, Daouya M, Funck T, Wu CL, Carosella ED, LeMaoult J, Hviid TVF, Faber C, Nissen MH.

Hum Immunol. 2017 May - Jun;78(5-6):414-420. doi: 10.1016/j.humimm.2017.04.007. Epub 2017 Apr 22.

PMID:
28442288
14.

Haplotypes of the HLA-G 3' Untranslated Region Respond to Endogenous Factors of HLA-G+ and HLA-G- Cell Lines Differentially.

Poras I, Yaghi L, Martelli-Palomino G, Mendes-Junior CT, Muniz YC, Cagnin NF, Sgorla de Almeida B, Castelli EC, Carosella ED, Donadi EA, Moreau P.

PLoS One. 2017 Jan 3;12(1):e0169032. doi: 10.1371/journal.pone.0169032. eCollection 2017.

15.

Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2.

Yaghi L, Poras I, Simoes RT, Donadi EA, Tost J, Daunay A, de Almeida BS, Carosella ED, Moreau P.

Oncotarget. 2016 Sep 27;7(39):63690-63707. doi: 10.18632/oncotarget.11628.

16.

Mesenchymal Stem Cells Derived from Human Bone Marrow and Adipose Tissue Maintain Their Immunosuppressive Properties After Chondrogenic Differentiation: Role of HLA-G.

Du WJ, Reppel L, Leger L, Schenowitz C, Huselstein C, Bensoussan D, Carosella ED, Han ZC, Rouas-Freiss N.

Stem Cells Dev. 2016 Oct 1;25(19):1454-69. doi: 10.1089/scd.2016.0022. Epub 2016 Jul 27.

PMID:
27465875
17.

Recombinant HLA-G as Tolerogenic Immunomodulant in Experimental Small Bowel Transplantation.

von Websky MW, Kitamura K, Ludwig-Portugall I, Kurts C, von Laffert M, LeMaoult J, Carosella ED, Abu-Elmagd K, Kalff JC, Schäfer N.

PLoS One. 2016 Jul 12;11(7):e0158907. doi: 10.1371/journal.pone.0158907. eCollection 2016.

18.

Immunomodulation of classical and non-classical HLA molecules by ionizing radiation.

Gallegos CE, Michelin S, Dubner D, Carosella ED.

Cell Immunol. 2016 May;303:16-23. doi: 10.1016/j.cellimm.2016.04.005. Epub 2016 Apr 18. Review.

PMID:
27113815
19.

Multiplex bead-based immunoassay for the free soluble forms of the HLA-G receptors, ILT2 and ILT4.

Wu CL, Svendsen SG, Riviere A, Desgrandchamps F, Carosella ED, LeMaoult J.

Hum Immunol. 2016 Sep;77(9):720-6. doi: 10.1016/j.humimm.2016.01.017. Epub 2016 Feb 10.

PMID:
26874236
20.

Pseudomonas aeruginosa Quorum Sensing Molecule N-(3-Oxododecanoyl)-L-Homoserine-Lactone Induces HLA-G Expression in Human Immune Cells.

Bortolotti D, LeMaoult J, Trapella C, Di Luca D, Carosella ED, Rizzo R.

Infect Immun. 2015 Oct;83(10):3918-25. doi: 10.1128/IAI.00803-15. Epub 2015 Jul 20. Erratum in: Infect Immun. 2017 Nov 17;85(12 ):.

21.

HLA-G: An Immune Checkpoint Molecule.

Carosella ED, Rouas-Freiss N, Tronik-Le Roux D, Moreau P, LeMaoult J.

Adv Immunol. 2015;127:33-144. doi: 10.1016/bs.ai.2015.04.001. Epub 2015 May 27. Review.

PMID:
26073983
22.

Trogocytic intercellular membrane exchanges among hematological tumors.

LeMaoult J, Caumartin J, Daouya M, Switala M, Rebmann V, Arnulf B, Carosella ED.

J Hematol Oncol. 2015 Mar 14;8:24. doi: 10.1186/s13045-015-0114-8.

23.

A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G.

Carosella ED, Ploussard G, LeMaoult J, Desgrandchamps F.

Eur Urol. 2015 Aug;68(2):267-79. doi: 10.1016/j.eururo.2015.02.032. Epub 2015 Mar 29. Review.

PMID:
25824720
24.

Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study.

Brugière O, Thabut G, Krawice-Radanne I, Rizzo R, Dauriat G, Danel C, Suberbielle C, Mal H, Stern M, Schilte C, Pretolani M, Carosella ED, Rouas-Freiss N.

Am J Transplant. 2015 Feb;15(2):461-71. doi: 10.1111/ajt.12977. Epub 2014 Dec 8.

25.

Osteodifferentiated mesenchymal stem cells from bone marrow and adipose tissue express HLA-G and display immunomodulatory properties in HLA-mismatched settings: implications in bone repair therapy.

Montespan F, Deschaseaux F, Sensébé L, Carosella ED, Rouas-Freiss N.

J Immunol Res. 2014;2014:230346. doi: 10.1155/2014/230346. Epub 2014 Apr 30.

26.

The dual role of HLA-G in cancer.

Rouas-Freiss N, Moreau P, LeMaoult J, Carosella ED.

J Immunol Res. 2014;2014:359748. doi: 10.1155/2014/359748. Epub 2014 Mar 31. Review.

27.

Kidney transplant recipients treated with belatacept exhibit increased naïve and transitional B cells.

Leibler C, Matignon M, Pilon C, Montespan F, Bigot J, Lang P, Carosella ED, Cohen J, Rouas-Freiss N, Grimbert P, Menier C.

Am J Transplant. 2014 May;14(5):1173-82. doi: 10.1111/ajt.12721. Epub 2014 Apr 14.

28.

[HLA-G: from feto-maternal tolerance to organ acceptance].

Carosella ED.

Bull Acad Natl Med. 2014 Apr-May;198(4-5):801-11; discussion 812. Review. French.

PMID:
26753410
29.

In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance.

Loumagne L, Baudhuin J, Favier B, Montespan F, Carosella ED, Rouas-Freiss N.

Int J Cancer. 2014 Nov 1;135(9):2107-17. doi: 10.1002/ijc.28845. Epub 2014 Apr 7.

30.

HLA-G1 increases the radiosensitivity of human tumoral cells.

Gallegos CE, Michelin S, Trasci SB, Lobos EA, Dubner D, Carosella ED.

Cell Immunol. 2014 Feb;287(2):106-11. doi: 10.1016/j.cellimm.2014.01.005. Epub 2014 Jan 15.

PMID:
24487034
31.

Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses.

Naji A, Menier C, Morandi F, Agaugué S, Maki G, Ferretti E, Bruel S, Pistoia V, Carosella ED, Rouas-Freiss N.

J Immunol. 2014 Feb 15;192(4):1536-46. doi: 10.4049/jimmunol.1300438. Epub 2014 Jan 22.

32.

Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population.

Martelli-Palomino G, Pancotto JA, Muniz YC, Mendes-Junior CT, Castelli EC, Massaro JD, Krawice-Radanne I, Poras I, Rebmann V, Carosella ED, Rouas-Freiss N, Moreau P, Donadi EA.

PLoS One. 2013 Oct 25;8(10):e71742. doi: 10.1371/journal.pone.0071742. eCollection 2013.

33.

Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy.

Naji A, Rouas-Freiss N, Durrbach A, Carosella ED, Sensébé L, Deschaseaux F.

Stem Cells. 2013 Nov;31(11):2296-303. doi: 10.1002/stem.1494. Review.

34.

Synthetic HLA-G proteins for therapeutic use in transplantation.

LeMaoult J, Daouya M, Wu J, Loustau M, Horuzsko A, Carosella ED.

FASEB J. 2013 Sep;27(9):3643-51. doi: 10.1096/fj.13-228247. Epub 2013 Jun 10.

35.

HLA-G 2012 conference: the 15-year milestone update.

Loustau M, Wiendl H, Ferrone S, Carosella ED.

Tissue Antigens. 2013 Mar;81(3):127-36. doi: 10.1111/tan.12053. Epub 2013 Jan 24.

PMID:
23347068
36.

Opening address to the 6th International Conference on HLA-G.

Carosella ED.

Hum Immunol. 2013 Apr;74(4):404. doi: 10.1016/j.humimm.2012.11.028. Epub 2012 Dec 8. No abstract available.

PMID:
23232061
37.

Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric study.

Wastowski IJ, Simões RT, Yaghi L, Donadi EA, Pancoto JT, Poras I, Lechapt-Zalcman E, Bernaudin M, Valable S, Carlotti CG Jr, Flajollet S, Jensen SS, Ferrone S, Carosella ED, Kristensen BW, Moreau P.

Am J Pathol. 2013 Feb;182(2):540-52. doi: 10.1016/j.ajpath.2012.10.021. Epub 2012 Dec 4.

38.

Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors.

HoWangYin KY, Loustau M, Wu J, Alegre E, Daouya M, Caumartin J, Sousa S, Horuzsko A, Carosella ED, LeMaoult J.

Cell Mol Life Sci. 2012 Dec;69(23):4041-9. doi: 10.1007/s00018-012-1069-3. Epub 2012 Jul 17.

39.

HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: the influence of the tumor microenvironment.

Zilberman S, Schenowitz C, Agaugué S, Benoît F, Riteau B, Rouzier R, Carosella ED, Rouas-Freiss N, Menier C.

Eur J Immunol. 2012 Jun;42(6):1599-608. doi: 10.1002/eji.201141761.

40.

The immunosuppressive molecule HLA-G and its clinical implications.

González A, Rebmann V, LeMaoult J, Horn PA, Carosella ED, Alegre E.

Crit Rev Clin Lab Sci. 2012 May-Jun;49(3):63-84. doi: 10.3109/10408363.2012.677947. Epub 2012 Apr 26. Review.

PMID:
22537084
41.

Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction.

Naji A, Menier C, Maki G, Carosella ED, Rouas-Freiss N.

Leukemia. 2012 Aug;26(8):1889-92. doi: 10.1038/leu.2012.62. Epub 2012 Mar 5. No abstract available.

PMID:
22441169
42.

HLA-G inhibition of NK-cell cytolytic function is uncoupled from tumor cell lipid raft reorganization.

Baudhuin J, Lesport E, Sousa S, Migraine J, Vigneron J, Lemaoult J, Carosella ED, Mooney N, Favier B.

Eur J Immunol. 2012 Mar;42(3):700-9. doi: 10.1002/eji.201141930. Epub 2012 Jan 19.

43.

The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells.

Carosella ED, Gregori S, LeMaoult J.

Blood. 2011 Dec 15;118(25):6499-505. doi: 10.1182/blood-2011-07-370742. Epub 2011 Sep 29. Review.

PMID:
21960588
44.

Tolerogenic function of dimeric forms of HLA-G recombinant proteins: a comparative study in vivo.

Favier B, HoWangYin KY, Wu J, Caumartin J, Daouya M, Horuzsko A, Carosella ED, LeMaoult J.

PLoS One. 2011;6(7):e21011. doi: 10.1371/journal.pone.0021011. Epub 2011 Jul 14.

45.

Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17.

Agaugué S, Carosella ED, Rouas-Freiss N.

Blood. 2011 Jun 30;117(26):7021-31. doi: 10.1182/blood-2010-07-294389. Epub 2011 Apr 11.

PMID:
21482709
46.

Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer.

Lesport E, Baudhuin J, Sousa S, LeMaoult J, Zamborlini A, Rouas-Freiss N, Carosella ED, Favier B.

Cell Mol Life Sci. 2011 Oct;68(20):3385-99. doi: 10.1007/s00018-011-0632-7. Epub 2011 Feb 20. Erratum in: Cell Mol Life Sci. 2011 Oct;68(20):3401.

PMID:
21337044
47.

The tolerogenic molecule HLA-G.

Carosella ED.

Immunol Lett. 2011 Jul;138(1):22-4. doi: 10.1016/j.imlet.2011.02.011. Epub 2011 Feb 17. Review. No abstract available.

PMID:
21333680
48.

HLA-G expression in human embryonic stem cells and preimplantation embryos.

Verloes A, Van de Velde H, LeMaoult J, Mateizel I, Cauffman G, Horn PA, Carosella ED, Devroey P, De Waele M, Rebmann V, Vercammen M.

J Immunol. 2011 Feb 15;186(4):2663-71. doi: 10.4049/jimmunol.1001081. Epub 2011 Jan 19.

49.

Proper regrafting of Ig-like transcript 2 after trogocytosis allows a functional cell-cell transfer of sensitivity.

HoWangYin KY, Caumartin J, Favier B, Daouya M, Yaghi L, Carosella ED, LeMaoult J.

J Immunol. 2011 Feb 15;186(4):2210-8. doi: 10.4049/jimmunol.1000547. Epub 2011 Jan 17.

50.

The role of HLA-G in immunity and hematopoiesis.

Carosella ED, Gregori S, Rouas-Freiss N, LeMaoult J, Menier C, Favier B.

Cell Mol Life Sci. 2011 Feb;68(3):353-68. doi: 10.1007/s00018-010-0579-0. Epub 2010 Nov 30. Review.

PMID:
21116680

Supplemental Content

Loading ...
Support Center